The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Analysis of Loss of Heterozygosity in 399 Premalignant Breast Lesions at 15 Genetic Loci
Abstract
BACKGROUND: Usual ductal hyperplasia (UDH), atypical ductal hyperplasia (ADH), and ductal carcinoma in situ (DCIS) are risk factors for invasive breast cancer (IBC), suggesting that these lesions may be direct precursors of IBC. To identify genetic changes that may be important in the early development of precursor lesions and their progression to malignant or invasive disease, we examined 399 putative precursors (211 UDH, 51 ADH, 81 non-comedo DCIS, and 56 comedo DCIS) for loss of heterozygosity (LOH) at 15 polymorphic genetic loci known to exhibit high rates of loss in IBC. We also assessed the sharing of LOH by putative precursors and synchronous cancers. METHODS: The polymerase chain reaction was used to analyze DNA from microdissected archival specimens. RESULTS AND CONCLUSIONS: In hyperplasias from noncancerous breasts (i.e., without DCIS and/or IBC in analyses of hyperplasias), LOH at any given locus was rare (range, 0%-15%), although 37% of UDH and 42% of ADH lesions showed loss for at least one locus, suggesting that the development of hyperplasias can involve many different tumor suppressor genes. In DCIS from noncancerous breasts (i.e., without IBC in analyses of DCIS), LOH was common, with 70% of noncomedo lesions and 79% of comedo lesions showing at least one loss. In DCIS, substantial rates of loss (up to 37%) were observed at loci on chromosomes 16q, 17p, and 17q, suggesting that inactivated tumor suppressor genes in these regions may be important in the development of noninvasive breast cancer. When DCIS lesions from cancerous and noncancerous breasts were compared, substantially more LOH was observed in the cancerous breasts at a few loci (on chromosomes 2p, 11p, and 17q), suggesting that genetic alterations in these regions may be important in the progression to invasive disease. Among specimens harvested from cancerous breasts, 37% of UDH, 45% of ADH, 77% of noncomedo DCIS, and 80% of comedo DCIS lesions shared LOH with synchronous cancers at one locus or more, supporting the idea that the putative precursors and the cancers are genetically related.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1968) · American Association of Industrial Nurses Journal · doi:10.1177/216507996801601208 · Cited by 8,798
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Mutations in the p53 gene occur in diverse human tumour types
Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hosteller, R., Cleary, K., Signer, S. H., Davidson, N., Baylin, S., Devilee, P., et al. (1989) · Nature · doi:10.1038/342705a0 · Cited by 2,733
Localization of a Breast Cancer Susceptibility Gene, BRCA2 , to Chromosome 13q12-13
Wooster, R., Neuhausen, S. L., Mangion, J., Quirk, Y., Ford, D., Collins, N., Nguyen, K., Seal, S., Tran, T., Averill, D., et al. (1994) · Science · doi:10.1126/science.8091231 · Cited by 1,924
Expression of recessive alleles by chromosomal mechanisms in retinoblastoma
Cavenee, W. K., Dryja, T. P., Phillips, R. A., Benedict, W. F., Godbout, R., Gallie, B. L., Murphree, A. L., Strong, L. C., & White, R. L. (1983) · Nature · doi:10.1038/305779a0 · Cited by 1,920
Risk Factors for Breast Cancer in Women with Proliferative Breast Disease
Dupont, W. D., & Page, D. L. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120303 · Cited by 1,829
Human Retinoblastoma Susceptibility Gene: Cloning, Identification, and Sequence
Lee, W.-H., Bookstein, R., Hong, F., Young, L.-J., Shew, J.-Y., & Lee, E. Y.-H. P. (1987) · Science · doi:10.1126/science.3823889 · Cited by 1,417
当科におけるせき髄しゅよう術後の長期経過観察 術後せき柱変形について
Shidahara, S., Marui, S., Akiyama, T., & Wakita, Y. (1982) · Orthopedics & Traumatology · doi:10.5035/nishiseisai.30.715 · Cited by 1,299
Zacks, C. M., Abbott, R. L., & Fine, M. (1990) · Cornea · doi:10.1097/00003226-199004000-00002 · Cited by 1,234
Cawthon, R. M., Weiss, R., Xu, G., Viskochil, D., Culver, M., Stevens, J., Robertson, M., Dunn, D., Gesteland, R., O'Connell, P., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90253-b · Cited by 1,094
Self-citationDeletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus
Viskochil, D., Buchberg, A. M., Xu, G., Cawthon, R. M., Stevens, J., Wolff, R. K., Culver, M., Carey, J. C., Copeland, N. G., Jenkins, N. A., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90252-a · Cited by 1,082
Self-citationAtypical hyperplastic lesions of the female breast. A long-term follow-up study
Page, D. L., Dupont, W. D., Rogers, L. W., & Rados, M. S. (1985) · Cancer · doi:10.1002/1097-0142(19850601)55:11<2698::aid-cncr2820551127>3.0.co;2-a · Cited by 961
E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers.
Berx, G., Cleton-Jansen, A. M., Nollet, F., de Leeuw, W. J., van de Vijver, M., Cornelisse, C., & van Roy, F. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00301.x · Cited by 775
(1975) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/55.2.231 · Cited by 750
Intraductal carcinoma of the breast: Follow-up after biopsy only
Page, D. L., Dupont, W. D., Rogers, L. W., & Landenberger, M. (1982) · Cancer · doi:10.1002/1097-0142(19820215)49:4<751::aid-cncr2820490426>3.0.co;2-y · Cited by 608
Loss of Heterozygosity in Normal Tissue Adjacent to Breast Carcinomas
Deng, G., Lu, Y., Zlotnikov, G., Thor, A. D., & Smith, H. S. (1996) · Science · doi:10.1126/science.274.5295.2057 · Cited by 582
SAMPLE PREPARATION FROM PARAFFIN-EMBEDDED TISSUES
Wright, D. K., & Manos, M. M. (1990) · PCR Protocols · doi:10.1016/b978-0-12-372180-8.50023-8 · Cited by 545
Breast cancer risk associated with proliferative breast disease and atypical hyperplasia
Dupont, W. D., Parl, F. F., Hartmann, W. H., Brinton, L. A., Winfield, A. C., Worrell, J. A., Schuyler, P. A., & Plummer, W. D. (1993) · Cancer · doi:10.1002/1097-0142(19930215)71:4<1258::aid-cncr2820710415>3.0.co;2-i · Cited by 528
A Prospective Study of Benign Breast Disease and the Risk of Breast Cancer
London, S. J. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480070057030 · Cited by 504
Smith, S. A., Easton, D. F., Evans, D. G. R., & Ponder, B. A. J. (1992) · Nature Genetics · doi:10.1038/ng1092-128 · Cited by 411
Genetic basis for p53 overexpression in human breast cancer.
Davidoff, A. M., Humphrey, P. A., Iglehart, J. D., & Marks, J. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.5006 · Cited by 285
Identification of the neurofibromatosis type 1 gene product.
Gutmann, D. H., Wood, D. L., & Collins, F. S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9658 · Cited by 278
Histologic types of benign breast disease and the risk for breast cancer
McDivitt, R. W., Stevensm, J. A., Lee, N. C., Wingo, P. A., Rubin, G. L., Gersell, D., & The Cancer And Steroid Hormone Study Group (1992) · Cancer · doi:10.1002/1097-0142(19920315)69:6<1408::aid-cncr2820690617>3.0.co;2-c · Cited by 212
Lakhani, S. R., Collins, N., Stratton, M. R., & Sloane, J. P. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.611 · Cited by 204
Risk of breast cancer in women with benign breast disease.
Hutchinson, W. B., Thomas, D. B., Hamlin, W. B., Roth, G. J., Peterson, A. V., & WILLIAMS, B. J. (1980) · PubMed · Cited by 199
Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas.
Varley, J. M., Brammar, W. J., Lane, D. P., Je, S., Dolan, C., & Ra, W. (1991) · PubMed · Cited by 198
Genetic divergence in the clonal evolution of breast cancer.
Fujii, H., Marsh, C., Cairns, P., Sidransky, D., & Gabrielson, E. (1996) · PubMed · Cited by 163
Radford, D. M., Fair, K., Phillips, N. J., Ritter, J. H., Steinbrueck, T., Holt, M. S., & Donis-Keller, H. (1995) · PubMed · Cited by 159
Aldaz, C. M., Chen, T.-X., Şahin, A. A., Cunningham, J. G., & Bondy, M. L. (1995) · PubMed · Cited by 137
Zhuang, Z., Merino, M. J., Chuaqui, R., Liotta, L. A., & Emmert-Buck, M. R. (1995) · PubMed · Cited by 125
Molecular genetic studies of early breast cancer evolution
O'Connell, P., Pekkel, V., Fuqua, S. A. W., Osborne, C. K., & Allred, D. C. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00666201 · Cited by 118
Self-citationChromosome 11q13 markers and D-type cyclins in breast cancer
Peters, G. G., Fantl, V., Smith, R., Brookes, S., & Dickson, C. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00682720 · Cited by 67
Friedman, L. S., Ostermeyer, E. A., Lynch, E. D., Szabo, C. I., Anderson, L. A., Dowd, P., Lee, M. K., Rowell, S. E., Boyd, J. A., & King, M. (1994) · PubMed · Cited by 56
Kasami, M., Vnencak‐Jones, C. L., Manning, S., Dupont, W. D., & Page, D. L. (1997) · Europe PMC (PubMed Central) · Cited by 51
Loss of heterozygosity of the oestrogen receptor gene in breast cancer
Iwase, H., Greenman, J., Barnes, D. M., Bobrow, L. G., Hodgson, S. V., & Mathew, C. G. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.91 · Cited by 42
Cited by
Gene expression profiles of human breast cancer progression
Ma, X.-J., Salunga, R., Tuggle, J. T., Gaudet, J., Enright, E., McQuary, P., Payette, T., Pistone, M., Stecker, K., Zhang, B. M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931261100 · Cited by 887
Chromosome aberrations in solid tumors
Albertson, D. G., Collins, C., McCormick, F., & Gray, J. W. (2003) · Nature Genetics · doi:10.1038/ng1215 · Cited by 812
Telomeres in cancer: tumour suppression and genome instability
Maciejowski, J., & de Lange, T. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.171 · Cited by 745
Ductal Carcinoma in Situ of the Breast
Burstein, H. J., Polyak, K., Wong, J. S., Lester, S. C., & Kaelin, C. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031301 · Cited by 759
MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study
Kuhl, C. K., Schrading, S., Bieling, H. B., Wardelmann, E., Leutner, C. C., Koenig, R., Kuhn, W., & Schild, H. H. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61232-x · Cited by 711
Metadata
- Authors
- O'Connell, P., Pekkel, V., Allred, D. C., Fuqua, S. A. W., Osborne, C. K., & Clark, G. M.
- Venue
- JNCI: Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-05-06
- Volume
- 90
- Issue
- 9
- Pages
- 697-703
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2002978719
- Cited by
- 340
- References
- 35
- FWCI
- 17.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.